Owner Scorecard


← All companies ← RMBS Manual RMNI → ← QTEX Medical Devices & Equipment SI →

RMD, ResMed Inc.

Medical Devices & Equipment consumer brand Serial acquirer

We are a global leader in digital health and cloud-connected medical devices.

We design innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives.

Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases.

Latest annual: FY2025 10-K
RMD · ResMed Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$5.1B
+9.8% YoY · 12% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $5.5B 5-yr avg $4.2B
Gross margin 62% 5-yr avg 57%
Operating margin 34.2% 5-yr avg 28.8%
ROIC 27% 5-yr avg 20%
Owner-earnings margin 32% 5-yr avg 20%
Free cash flow margin 32% 5-yr avg 20%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What it is
Revenue is Sleep and Breathing Health (88%) and Residential Care Software (12%).
Situation
Serial acquirer. Goodwill and acquired intangibles are 43% of assets, with meaningful acquisition spending in 5 of the record's 10 years; much of what this business is was bought, at prices the record carries.
What moves the needle
Gross margin has run about 57% and operating margin about 27% through the cycle, a wide spread between price and the cost of what it sells — whether that advantage is durable pricing power or a margin that can erode is the question the record is for. Inventory runs near 14% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on customer concentration, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has run in the teens (median 17%, above 15% in 8 of 10 years). Owner earnings agree: roughly 19% of revenue reaches owners as cash, consistently. Returns like these are solid but short of clear franchise economics; whether they hold is what the 10-K settles, not the multiple.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

Sleep and Breathing Health is 88% of revenue, with Residential Care Software the other meaningful segment at 12%.

Revenue by reportable segment, FY2025
  • Sleep and Breathing Health88%$4.5B
  • Residential Care Software12%$641M
By geographyUnited States64%Rest Of World36%

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMMar 2026
Income statement
$1.8B$2.1B$2.3B$2.6B$3.0B$3.2B$3.6B$4.2B$4.7B$5.1B$5.5BRevenueRevenue
58%58%57%57%58%58%57%56%57%59%62%Gross marginGross mgn
27%27%26%25%23%21%21%21%20%19%20%SG&A / revenueSG&A/rev
6%7%7%7%7%7%7%7%7%6%6%R&D / revenueR&D/rev
$429M$426M$542M$579M$810M$904M$1.0B$1.1B$1.3B$1.7B$1.9BOperating incomeOp. inc.
23.3%20.6%23.2%22.2%27.4%28.3%28.0%26.8%28.2%32.7%34.2%Operating marginOp. mgn
$352M$342M$316M$405M$622M$475M$779M$898M$1.0B$1.4B$1.5BNet incomeNet inc.
20%18%39%22%15%46%19%19%19%17%20%Effective tax rateTax rate
Cash flow & returns
$548M$414M$505M$459M$802M$737M$351M$693M$1.4B$1.8B$1.9BOperating cash flowOp. cash
$87M$112M$120M$151M$155M$157M$160M$165M$177M$198M$220MDepreciationDeprec.
$62M($86M)$21M($148M)($32M)$42M($653M)($441M)$123M$61M$49MWorking capital & otherWC & other
$59M$62M$63M$69M$95M$103M$135M$120M$99M$90M$136MCapexCapex
3.2%3.0%2.7%2.6%3.2%3.2%3.8%2.8%2.1%1.7%2.5%Capex / revenueCapex/rev
$489M$352M$442M$390M$707M$634M$216M$574M$1.3B$1.7B$1.8BOwner earningsOwner earn.
26.6%17.0%18.9%15.0%23.9%19.8%6.0%13.6%27.8%32.3%31.7%Owner earnings marginOE mgn
$489M$352M$442M$390M$707M$634M$216M$574M$1.3B$1.7B$1.8BFree cash flowFCF
26.6%17.0%18.9%15.0%23.9%19.8%6.0%13.6%27.8%32.3%31.7%Free cash flow marginFCF mgn
$1.0B$7M$902K$951M$28M$39M$43M$1.0B$133M$139M$164MAcquisitionsAcquis.
$168M$186M$199M$212M$225M$227M$245M$258M$282M$311M$340MDividends paidDiv. paid
$102M$54M$23M$0$0$150M$300MBuybacksBuybacks
16%16%15%14%21%15%21%17%20%26%27%ROICROIC
21%17%15%20%25%16%23%22%21%23%23%Return on equityROE
11%8%6%9%16%9%16%15%15%18%18%Retained to equityRetained/eq
Balance sheet
$731M$822M$189M$147M$463M$295M$274M$228M$238M$1.2B$1.7BCash & investmentsCash+inv
$382M$451M$484M$528M$475M$614M$576M$705M$837M$939M$999MReceivablesReceiv.
$224M$268M$269M$350M$417M$457M$744M$998M$822M$928M$912MInventoryInvent.
$93M$93M$93M$116M$136M$138M$159M$151M$238M$278M$273MAccounts payablePayables
$514M$626M$660M$762M$756M$933M$1.2B$1.6B$1.4B$1.6B$1.6BOperating working capitalOper. WC
$1.4B$1.6B$1.1B$1.1B$1.5B$1.6B$1.9B$2.4B$2.4B$3.5B$4.1BCurrent assetsCur. assets
$638M$360M$511M$556M$603M$912M$689M$759M$911M$1.0B$1.4BCurrent liabilitiesCur. liab.
2.2×4.6×2.1×2.1×2.5×1.7×2.8×3.1×2.6×3.4×3.0×Current ratioCurr. ratio
$1.1B$1.1B$1.1B$1.9B$1.9B$1.9B$1.9B$2.8B$2.8B$3.0B$3.0BGoodwillGoodwill
$3.3B$3.5B$3.1B$4.1B$4.6B$4.7B$5.1B$6.8B$6.9B$8.2B$8.8BTotal assetsAssets
$1.2B$1.1B$281M$1.3B$1.2B$655M$775M$1.4B$707M$668M$664MTotal debtDebt
$441M$257M$93M$1.1B$713M$360M$502M$1.2B$469M($541M)($996M)Net debt / (cash)Net debt
38.3×15.1×19.1×16.0×20.1×37.7×84.4×Interest coverageInt. cov.
$1.7B$2.0B$2.1B$2.1B$2.5B$2.9B$3.4B$4.1B$4.9B$6.0B$6.5BShareholders’ equityEquity
2.5%2.2%2.1%2.0%1.9%2.0%1.8%1.7%1.7%1.8%1.8%Stock comp / revenueSBC/rev
Per share
142M142M144M144M146M146M147M147M148M147M146MShares out (diluted)Shares
$12.98$14.51$16.25$18.04$20.30$21.83$24.33$28.64$31.75$34.93$37.83Revenue / shareRev/sh
$2.49$2.40$2.19$2.80$4.27$3.24$5.30$6.09$6.92$9.51$10.38EPS (diluted)EPS
$3.45$2.47$3.07$2.70$4.85$4.33$1.47$3.89$8.82$11.28$11.98Owner earnings / shareOE/sh
$3.45$2.47$3.07$2.70$4.85$4.33$1.47$3.89$8.82$11.28$11.98Free cash flow / shareFCF/sh
$1.19$1.31$1.39$1.47$1.55$1.55$1.67$1.75$1.91$2.11$2.32Dividends / shareDiv/sh
$0.41$0.44$0.43$0.48$0.65$0.70$0.92$0.81$0.67$0.61$0.93Cap. spending / shareCapex/sh
$11.96$13.76$14.30$14.34$17.14$19.70$22.86$28.01$32.97$40.50$44.35Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+11.6%/yr+11.5%/yr
Owner earnings / share+14.0%/yr+18.4%/yr
EPS+16.1%/yr+17.4%/yr
Dividends / share+6.6%/yr+6.4%/yr
Capital spending / share+4.4%/yr−1.4%/yr
Book value / share+14.5%/yr+18.8%/yr

The year, in the company's words

the filing →

Verbatim from the 10-K's management discussion. Each sentence is shown only because its subject, direction, and stated figures check out against the filed numbers on this page. The words are the company's; the arithmetic is the record's.

  • Residential Care Software+9.8%
    “Residential Care Software Net revenue from our Residential Care Software business for the year ended June 30, 2025 was $641.4 million, compared to $584.1 million for the year ended June 30, 2024, an increase of $57.3 million or 10%. The increase was driven by continued growth in the Home Medical Equipment, or HME, and MEDIFOX DAN verticals within our Residential Care Software business.”
    ✓ figure matches the filed record

The record, charted

FY2016–2025

Each measure over its full record; the current point and the worst year marked.

Share count
147Mpeak FY2024
ROIC
26%low FY2019
Gross margin
59%low FY2023

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

$1.7Bowner earningsvs.$1.4Bnet incomelow FY2022

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2016FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned $1.4B of profit into $1.7B of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$1.4B
Owner earnings$1.7B · 32% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$1.4B$1.0B$898M$779M$475M
Depreciation & amortizationnon-cash charge added back+$198M+$177M+$165M+$160M+$157M
Stock-based compensationreal costnon-cash, but a real cost+$92M+$80M+$71M+$65M+$64M
Working capital & othertiming of cash in and out, other non-cash items+$61M+$123M−$441M−$653M+$42M
Cash from operations$1.8B$1.4B$693M$351M$737M
Capital expenditurecash put back in to keep running and to grow−$90M−$99M−$120M−$135M−$103M
Owner earnings$1.7B$1.3B$574M$216M$634M
Owner-earnings marginowner earnings ÷ revenue32%28%14%6%20%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $92M), owner earnings is nearer $1.6B.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Comfortable
    Operating income $1.7B ÷ interest expense $24M
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • Net cash
    Cash $1.2B − debt $668M
    What this means

    Cash and short-term investments exceed every dollar of debt by $541M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 67 + DIO 162 − DPO 49 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • High through the cycle
    10-yr median, range 14%–26%; 26% latest = NOPAT $1.4B ÷ invested capital $5.4B
    Industry peers: median 11%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 10 years (it ran 26% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • High through the cycle
    10-yr median margin, range 6%–32%; latest $1.7B = operating cash $1.8B − maintenance capex $90M
    Industry peers: median 17%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 32% of revenue this year, a 19% median across 10 years. Treating stock comp as the real expense it is (less $92M of SBC) leaves $1.6B.

  • Cash-backed
    Cash from ops $1.8B ÷ net income $1.4B

    In the filing’s words The filing leans on adjusted, non-GAAP earnings, but the GAAP profit is itself cash-backed — the adjustments are not papering over a cash shortfall here.

    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Reinvests most of it
    Dividends + buybacks $611M ÷ Owner Earnings $1.7B
    What this means

    Of $1.7B Owner Earnings, $611M (37%) went back to shareholders, $311M dividends, $300M buybacks. Net of $92M stock comp, the real buyback was about $208M. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.

  • Investing or harvesting? 0.45×
    Harvesting
    Capex $90M ÷ depreciation $198M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 6 of 6 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Pass
    Revenue ≥ $2B · $5.1B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 3.44×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $668M vs $2.5B WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Pass
    A profit every year (10-yr record) · no losses
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Pass
    Uninterrupted dividends · paid every year (10)
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth Pass
    Earnings +33% over the record · +229%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $7.63/share (latest year $9.66), the averaged base the calculator's gate runs on, and book value is $41.14/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 10 of 10
    What this means

    Never lost money over the record, the earnings stability Graham insisted on.

  • Return on capital ≥ 15% 8 of 10 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 22% → 29% (3-yr avg ends)

    In the filing’s words The margin widened even though the filing names price competition — the gain came from volume or cost, not pricing power. Read where.

    What this means

    Through the cycle the operating margin widened — about 22% early to 29% lately, median 27% — pricing power intact or improving.

  • Reinvestment, incremental ROIC 25%
    What this means

    Every extra dollar the business reinvested came back at a high incremental return — the lens GBM read for a moat that reinvests rather than merely harvests. The record and the 10-K are where you check whether the rate holds.

  • Owner earnings growth +15%/yr
    What this means

    Owner earnings grew about 15% a year over the record.

  • Worst year 2017 · 20.6% op. margin
    What this means

    Stayed profitable even in its hardest year, the resilience that survives recessions.

  • Share count +0.4%/yr
    What this means

    Roughly flat share count, little dilution, little buyback.

  • Dividend record rising
    What this means

    Paid and raised the dividend across the record, the continuity Graham prized.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

In its own filing Named as a competitive risk

Its FY2025 10-K names artificial intelligence as a competitive threat.

“For Residential Care Software, the demand for business management software is highly competitive, rapidly evolving, subject to changing technology, with low barriers to entry, shifting customer needs, increased use of AI and frequent introductions of new products and services.”

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat, and the company is using it that way.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 31, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$4.1B
  • Cash & short-term investments$1.7B
  • Receivables$999M
  • Inventory$912M
  • Other current assets$493M
Current liabilities$1.4B
  • Debt due within a year$18K
  • Accounts payable$273M
  • Other current liabilities$1.1B
Current ratio3.01×all current assets ÷ what's due · Graham looked for 2×
Quick ratio2.33×stricter: inventory excluded
Cash ratio1.23×strictest: cash alone against what's due
Working capital$2.7Bthe cushion left after near-term bills
Debt due this year vs. cash$18K due · $1.7B cash covered by cash on hand, no refinancing forced · both figures from the Mar 31, 2026 balance sheet
Revenue, latest quarter vs. a year ago+10.8%the freshest read on whether the business is still growing
Current ratio, recent quarters2.6× → 3.0×
Deeper floors
Tangible book value$3.0Bequity stripped of goodwill & intangibles
Net current asset value$1.8BGraham's net-net: current assets less all liabilities
Debt incl. operating leases$583M$179M of it operating leases
Deferred revenue$342Mcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $7.7B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.

  • Reinvested$894M · 12%
  • Dividends$2.3B · 30%
  • Buybacks$629M · 8%
  • Retained (debt / cash)$3.8B · 50%
  • Returned to owners$2.9B

    43% of the owner earnings the business produced over the span, $2.3B as dividends and $629M as buybacks.

  • Average price paid for buybacks$215.33

    Across the years where the filing reports a share count, 2M shares were bought for $450M, about $215.33 each.

  • Net change in share count3.3%

    The diluted count rose from 142M to 146M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.

  • Dividend record$2.11/sh

    Paid in 10 of the years on record, the per-share dividend growing about 7% a year. It was never cut over the span.

  • Return on what it retained20%

    Of the earnings it kept rather than paid out ($3.7B over the span), annual owner earnings (first three years vs last three) grew $751M, so each retained $1 added about 0.20 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$3.5B43% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity51%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$3.4Bover 10 years buying other businesses, against $894M of capital spent building

None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2021Mr. Michael Farrell$10.4M$32.8M$634M
2022Mr. Michael Farrell$11.7M$4.4M$216M
2023Mr. Michael Farrell$13.9M$16.9M$574M
2024Mr. Michael Farrell$14.1M$10.3M$1.3B
2025Mr. Michael Farrell$14.7M$29.6M$1.7B

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership0.7%

    The stake all directors and executive officers hold together, per the 2025 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$92M

    The slice of the business handed to employees in shares this year, 2% of revenue, equal to 5% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why ResMed Inc. is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2016–2025.

1 of the 6 tests turned up something to look into; the other 5 came back clean.

  • Look hereDid the share count rise anyway?3.3%

    Diluted shares grew 3.3% over 2016–2025, even as the company spent $629M on buybacks. The repurchases were a treadmill: stock issued to staff outran them, so owners' slice still shrank. Read the buyback line beside this one, not on its own.

And these came back clean
  • Is it less profitable than it was?
  • Did debt outgrow the business?
  • Did reported profit become cash?
  • Did receivables and inventory outpace sales?
  • Are "one-time" charges a yearly habit?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition, Income taxes as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Medical Devices & Equipment

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
EWEdwards Lifesciences Corporation$6.1B76%25.7%22%23%
RMDResMed Inc.$5.1B57%27.1%17%19%
DXCMDexCom Inc.$4.7B65%12.1%10%17%
HOLXHologic$4.1B66%20.6%13%24%
ALGNAlign Technology$4.0B72%19.9%23%22%
MMEDMiniMed Group Inc.$3.1B56%-5.4%-3%-4%
GMEDGlobus Medical$2.9B75%19.9%11%17%
PODDInsulet Corporation$2.7B65%6.2%5%5%
Group median66%19.9%12%18%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what ResMed Inc. has delivered.

ResMed Inc.’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.

$

Through the cycle, ResMed Inc. earns about $997M on its 19.4% median owner-earnings margin. This year’s 32.3% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.

Base

The assumptions

9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25+37%/yr
Owner-earnings growth · ’16→’25+15%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Free cash flow $1.8B on 145M shares outstanding, per the 10-Q cover, as of 2026-04-27; net cash $996M. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. Capex ($136M) runs well above depreciation ($220M), so this is a build-out; Steady-state swaps total capex for maintenance (≈ depreciation), lifting the base to about $1.8B, the cash it would throw off if it stopped expanding. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "ResMed Inc. (RMD), the owner's record," https://ownerscorecard.com/c/RMD, data as of 2026-07-09.

Manual order: ← RMBS its page in the Manual RMNI →

Industry order: ← QTEX the Medical Devices & Equipment chapter SI →